REGISTER TODAY FOR ARM'S LEGISLATIVE FLY-IN & 8th ANNUAL DINNER COMING UP MAY 23-24, 2017 IN WASHINGTON, DC. ADVOCATE FOR THE PROGRESS OF ADVANCED THERAPIES -- LEARN ABOUT THE LATEST CLINICAL DEVELOPMENTS FROM PATIENTS AND RESEARCHERS -- NETWORK WITH THE FIELD'S TOP EXECS

JOIN ARM AT THE INAUGURAL CELL & GENE EXCHANGE TAKING PLACE MAY 22-23, 2017 IN WASHINGTON, DC. THIS PARTNERING MEETING IS FOCUSED ON BRINGING TOGETHER THE REGULATORY, BUSINESS AND PATIENT ADVOCACY COMMUNITIES. 

Learn more about ARM's 5th Annual Cell & Gene Therapy Investor Day - April 27, 2017 in Boston! Don't miss the only investor meeting organized specifically for the advanced therapies sector providing unique insight into 30+ top publicly traded and emerging private companies.

About ARM

Advancing Regenerative Medicine
The Alliance for Regenerative Medicine (ARM) is a Washington, DC-based multi-stakeholder advocacy organization that promotes legislative, regulatory and reimbursement initiatives necessary to facilitate access to life-giving advances in regenerative medicine. ARM also works to increase public understanding of the field and its potential to transform human healthcare, providing business development and investor outreach services to support the growth of its member companies and research organizations.
Learn more

Our Members

200+ and Growing
ARM’s membership is diverse, representing leading regenerative medicine companies and investors, university-based and non-profit research institutions, patient advocacy groups, pharmaceutical companies engaged in regenerative medicine research and other organizations supporting regenerative medicine.
Learn more